CIK 0001745999 · Large accelerated filer
Beam Therapeutics Inc.
Sign in to watch- Ticker
- BEAM
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 857-327-8775
- Business address
- 26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
- Former names
- Beam Therapeutics Inc.
- 4 Other disposition 10% owner disposed of 800,000 shares (other)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Material agreement · Unregistered share sale · Other events
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 4 Other acquisition 10% owner acquired 356,673 shares (other)
- 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 4 Open-market sale CFO sold 25,000 shares at an average $81.78 ($2,044,485)
- 4 Open-market sale President & CSO sold 43,842 shares at an average $83.26 ($3,650,144)
Page 22 of 26 · 514 filings